25th Anniversary
25 Years of Innovation
2021 marked 25 years since the foundation of EuropaBio aisbl and we have launched a year long celebration of biotechnology advances over the last quarter century.
During 2021, EuropaBio's Members have been nominating and selecting the scientific and business advances that have impacted people and planet and showcased them all, in addition to reviews of key sectors, sciences and the ecosystem in which biotechnology is delivered into action.
During 2021, EuropaBio's Members have been nominating and selecting the scientific and business advances that have impacted people and planet and showcased them all, in addition to reviews of key sectors, sciences and the ecosystem in which biotechnology is delivered into action.
Celebrating together
After a long period of our biotech community working apart, we are delighted to host 25th Anniversary Celebratons in Brussels in 2022. Members, Anniversary nominations, and special guests will come together to celebrate the role of biotechnology in making it possible and toasting the next generation of innovation to meet the needs of people and planet.
Creating the showcase
From May 2021, EuropaBio Members, Member companies of our National Associations and Anniversary sponsors have been nominating the advances in science and business from the last 25 years that they consider to be the most significant contributors to science, people and planet.
The dedicated 25th Anniversary timeline features science and company breakthroughs, supported with interviews, reviews and webinars from the key advances and the people who enabled them.
The dedicated 25th Anniversary timeline features science and company breakthroughs, supported with interviews, reviews and webinars from the key advances and the people who enabled them.
Anniversary index
2020
2018
2016
2015
It’s Coming…
2014
2012
2011
It’s Coming…
2010
It’s Coming…
2009
It’s Coming…
2008
It’s Coming…
2007
2006
2004
It’s Coming…
2000
1998
It’s Coming…
1996
Understanding How The Immune System Recognises Virus-Infected Cells. Nobel Prize For Physiology Or Medicine
First European Commission-Approved Product Following European Agency For The Evaluation Of Medicinal Products (EMEA, Later EMA) Recommendation
Introduction Of Law In Italy For Early Access To Drugs (648/1996) To Support Rare Disease Patients
